Puma Biotechnology, Inc. (PBYI)
5.73
+0.14
(+2.50%)
USD |
NASDAQ |
Dec 11, 16:00
5.74
+0.01
(+0.17%)
Pre-Market: 20:00
Puma Biotechnology Free Cash Flow: 42.87M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Nephros, Inc. | 2.719M |
| Sensus Healthcare, Inc. | 2.167M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Vanda Pharmaceuticals, Inc. | -82.95M |
| Vertex Pharmaceuticals, Inc. | 3.337B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 9.689M |
| Cash from Investing (Quarterly) | 0.506M |
| Cash from Financing (Quarterly) | -11.33M |
| Free Cash Flow Per Share (Quarterly) | 0.1897 |
| Free Cash Flow to Equity (Quarterly) | 17.84M |
| Free Cash Flow to Firm (Quarterly) | 11.09M |
| Free Cash Flow Yield | 14.93% |